Security key
00972D105
Akebia Therapeutics, Inc. - COMMON STOCK (AKBA)
CUSIP: 00972D105
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 270,093,163
- Total 13F shares
- 108,291,108
- Share change
- +12,527,818
- Total reported value
- $394,183,978
- Put/Call ratio
- 196%
- Price per share
- $3.64
- Number of holders
- 157
- Value change
- +$56,486,637
- Number of buys
- 109
- Number of sells
- 41
Report period
Q2 2025
Institutions
157
Top holders
10
AKBA full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Akebia Therapeutics, Inc. SEC filings
Akebia Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00972D105
Recent filing periods:
Top shareholders of AKBA - Akebia Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Muneer A. Satter |
13D/G
|
Satter Muneer A |
2.6%
|
5,747,906
|
$13,105,226 | $0 | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
5.7%
|
15,332,163
|
$29,437,752 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.7%
|
12,685,803
|
$24,356,741 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.5%
|
6,805,807
|
$13,067,149 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
5,030,740
|
$9,661,509 | — | 31 Mar 2025 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
1.8%
|
4,973,840
|
$9,549,773 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.5%
|
4,005,827
|
$7,691,188 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.4%
|
3,646,909
|
$7,002,066 | — | 31 Mar 2025 | |
| AIGH Capital Management LLC |
13F
|
Company |
1.1%
|
2,925,000
|
$5,616,000 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1%
|
2,724,439
|
$5,230,923 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.99%
|
2,681,198
|
$5,147,900 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.99%
|
2,667,327
|
$5,121,268 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.92%
|
2,485,578
|
$4,772,310 | — | 31 Mar 2025 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.74%
|
2,000,000
|
$3,840,000 | — | 31 Mar 2025 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.66%
|
1,777,911
|
$3,413,589 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.63%
|
1,711,191
|
$3,285,487 | — | 31 Mar 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.58%
|
1,579,355
|
$3,032,362 | — | 31 Mar 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.56%
|
1,500,000
|
$2,880,000 | — | 31 Mar 2025 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.56%
|
1,500,000
|
$2,880,000 | — | 31 Mar 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.46%
|
1,245,494
|
$2,391,348 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.45%
|
1,203,852
|
$2,311,396 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.4%
|
1,068,277
|
$2,051,092 | — | 31 Mar 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.36%
|
969,834
|
$1,862,081 | — | 31 Mar 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.34%
|
913,449
|
$1,753,822 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.32%
|
872,484
|
$1,675,168 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.27%
|
741,161
|
$1,423,029 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.25%
|
687,279
|
$1,319,576 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.25%
|
666,567
|
$1,279,808 | — | 31 Mar 2025 | |
| AXA S.A. |
13F
|
Company |
0.23%
|
627,892
|
$1,205,553 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.23%
|
622,914
|
$1,195,995 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.22%
|
592,410
|
$1,137,427 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.2%
|
535,431
|
$1,027,669 | — | 31 Mar 2025 | |
| Longaeva Partners L.P. |
13F
|
Company |
0.19%
|
500,000
|
$960,000 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.18%
|
493,593
|
$947,698 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.18%
|
481,910
|
$925,267 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.13%
|
350,413
|
$20,496,484 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.11%
|
308,135
|
$591,619 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.11%
|
306,000
|
$587,520 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.1%
|
282,066
|
$541,559 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.1%
|
260,603
|
$500,358 | — | 31 Mar 2025 | |
| MACKENZIE FINANCIAL CORP |
13F
|
Company |
0.09%
|
237,558
|
$456,111 | — | 31 Mar 2025 | |
| Creative Planning |
13F
|
Company |
0.09%
|
229,670
|
$440,966 | — | 31 Mar 2025 | |
| Diametric Capital, LP |
13F
|
Company |
0.08%
|
211,325
|
$405,744 | — | 31 Mar 2025 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.08%
|
206,630
|
$396,730 | — | 31 Mar 2025 | |
| Maven Securities LTD |
13F
|
Company |
0.07%
|
200,000
|
$384,000 | — | 31 Mar 2025 | |
| SAPIENT CAPITAL LLC |
13F
|
Company |
0.07%
|
200,000
|
$384,000 | — | 31 Mar 2025 | |
| Exome Asset Management LLC |
13F
|
Company |
0.07%
|
189,087
|
$363,047 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.07%
|
176,961
|
$339,764 | — | 31 Mar 2025 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.06%
|
175,045
|
$336,090 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.06%
|
173,431
|
$332,988 | — | 31 Mar 2025 |
Institutional Holders of Akebia Therapeutics, Inc. - COMMON STOCK (AKBA) as of Q2 2025
As of 30 Jun 2025,
Akebia Therapeutics, Inc. - COMMON STOCK (AKBA) was held by
157 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
108,291,108 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC, MPM BIOIMPACT LLC, Nuveen, LLC, and FRANKLIN RESOURCES INC.
This page lists
157
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
142
Q2 2025 holders
157
Holder diff
15
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.